To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the efficacy of ivermectin as a (a) prophylactic and (b) treatment for covid-19.
The Department continues to monitor evidence on the use of ivermectin both as a prophylactic and treatment for COVID-19. A recent collection of small studies shows some positive indications that ivermectin may act as a treatment for COVID-19. However, further high quality, larger-scale studies are still needed to confirm the safety and efficacy of this treatment. The Therapeutics Taskforce will keep the position on ivermectin under review as more data becomes available.